bioAffinity Technologies (BIAF) vs Fulgent Genetics (FLGT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Fulgent Genetics is the larger company by market cap ($598.2 million vs $5.5 million), about 108.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIAF | FLGT |
|---|---|---|
| Share price | $4.73 | $21.74 |
| Market cap | $5.51M | $598.18M |
| 1-day change | -16.22% | +4.42% |
| YTD return | — | -20.75% |
| 1-year return | — | -8.80% |
| 5-year return | — | -73.31% |
| EPS (TTM) | $-91.61 | $-2.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $80.70 | $31.04 |
| 52-week low | $4.56 | $13.46 |
| Distance from 52-week high | -94.14% | -29.96% |
| Analyst consensus | — | none |
| Avg. price target upside | — | -12.60% |
| Average volume | 3.73M | 302.46K |
| Shares outstanding | 1.17M | 27.52M |
| Employees | 57 | 1,315 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Fulgent Genetics is about 108.5 times larger than bioAffinity Technologies by market value ($598.18M vs $5.51M).
About bioAffinity Technologies
BIAF stock →bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 57 employees
About Fulgent Genetics
FLGT stock →Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Health Care · Medical Specialities · 1,315 employees
BIAF vs FLGT FAQ
Which is bigger, bioAffinity Technologies or Fulgent Genetics?
Fulgent Genetics (FLGT) is larger, with a market capitalization of $598.18M compared with $5.51M for bioAffinity Technologies (BIAF).
Are bioAffinity Technologies and Fulgent Genetics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Commercial Physical & Biological Resarch for bioAffinity Technologies and Medical Specialities for Fulgent Genetics.